Yajing Lv (Yajing Lyu)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 11

Top Topics

Cancer Stem Cells

Signaling Pathway

Optical Coherence Tomography

Top Venues

Science advances

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Walter Jackson, Yongkang Yang, Shaima Salman, Dominic Dordai, Yajing Lv, Emmanuel Datan, Daiana Drehmer, Tina Yi-Ting Huang, Yousang Hwang, Gregg L Semenza
Pharmacologic HIF stabilization activates costimulatory receptor expression to increase antitumor efficacy of adoptive T cell therapy. Science advances 10 (35) (2024)
Yongkang Yang, Chelsey Chen, Qiaozhu Zuo, Haiquan Lu, Shaima Salman, Yajing Lv, Tina Yi-Ting Huang, Elizabeth E Wicks, Walter Jackson, Emmanuel Datan, Ru Wang, Yufeng Wang, Nguyet Le, Yayun Zhu, Wenxin Qin, Gregg L Semenza
NARF is a hypoxia-induced coactivator for OCT4-mediated breast cancer stem cell specification. Science advances 8 (49) (2022)
Yongkang Yang, Chelsey Chen, Qiaozhu Zuo, Haiquan Lu, Shaima Salman, Yajing Lv, Tina Yi-Ting Huang, Elizabeth E Wicks, Walter Jackson, Emmanuel Datan, Ru Wang, Yufeng Wang, Nguyet Le, Yayun Zhu, Wenxin Qin, Gregg L Semenza
NARF is a hypoxia-induced coactivator for OCT4-mediated breast cancer stem cell specification. Science advances 8 (49) (2022)
Yongkang Yang, Chelsey Chen, Qiaozhu Zuo, Haiquan Lu, Shaima Salman, Yajing Lv, Tina Yi-Ting Huang, Elizabeth E Wicks, Walter Jackson, Emmanuel Datan, Ru Wang, Yufeng Wang, Nguyet Le, Yayun Zhu, Wenxin Qin, Gregg L Semenza
NARF is a hypoxia-induced coactivator for OCT4-mediated breast cancer stem cell specification. Science advances 8 (49) (2022)
Yongkang Yang, Chelsey Chen, Qiaozhu Zuo, Haiquan Lu, Shaima Salman, Yajing Lv, Tina Yi-Ting Huang, Elizabeth E Wicks, Walter Jackson, Emmanuel Datan, Ru Wang, Yufeng Wang, Nguyet Le, Yayun Zhu, Wenxin Qin, Gregg L Semenza
NARF is a hypoxia-induced coactivator for OCT4-mediated breast cancer stem cell specification. Science advances 8 (49) (2022)
Yongkang Yang, Chelsey Chen, Qiaozhu Zuo, Haiquan Lu, Shaima Salman, Yajing Lv, Tina Yi-Ting Huang, Elizabeth E Wicks, Walter Jackson, Emmanuel Datan, Ru Wang, Yufeng Wang, Nguyet Le, Yayun Zhu, Wenxin Qin, Gregg L Semenza
NARF is a hypoxia-induced coactivator for OCT4-mediated breast cancer stem cell specification. Science advances 8 (49) (2022)
Yongkang Yang, Chelsey Chen, Qiaozhu Zuo, Haiquan Lu, Shaima Salman, Yajing Lv, Tina Yi-Ting Huang, Elizabeth E Wicks, Walter Jackson, Emmanuel Datan, Ru Wang, Yufeng Wang, Nguyet Le, Yayun Zhu, Wenxin Qin, Gregg L Semenza
NARF is a hypoxia-induced coactivator for OCT4-mediated breast cancer stem cell specification. Science advances 8 (49) (2022)
Yongkang Yang, Haiquan Lu, Chelsey Chen, Yajing Lv, Robert N Cole, Gregg L Semenza
HIF-1 Interacts with TRIM28 and DNA-PK to release paused RNA polymerase II and activate target gene transcription in response to hypoxia. Nature communications 13 (1) (2022)
Yongkang Yang, Chelsey Chen, Qiaozhu Zuo, Haiquan Lu, Shaima Salman, Yajing Lv, Tina Yi-Ting Huang, Elizabeth E Wicks, Walter Jackson, Emmanuel Datan, Ru Wang, Yufeng Wang, Nguyet Le, Yayun Zhu, Wenxin Qin, Gregg L Semenza
NARF is a hypoxia-induced coactivator for OCT4-mediated breast cancer stem cell specification. Science advances 8 (49) (2022)
Yufeng Wang, Yajing Lv, Kangsheng Tu, Qiuran Xu, Yongkang Yang, Shaima Salman, Nguyet Le, Haiquan Lu, Chelsey Chen, Yayun Zhu, Ru Wang, Qingguang Liu, Gregg L Semenza
Histone citrullination by PADI4 is required for HIF-dependent transcriptional responses to hypoxia and tumor vascularization. Science advances 7 (35) (2021)
Yajing Lv, Xiaoshuang Wang, Xiaoyu Li, Guangwei Xu, Yuting Bai, Jiayi Wu, Yongjun Piao, Yi Shi, Rong Xiang, Longlong Wang
Nucleotide de novo synthesis increases breast cancer stemness and metastasis via cGMP-PKG-MAPK signaling pathway. PLoS biology 18 (11) (2020)